Search results
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
Proactive Investors· 7 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
AstraZeneca jumps on covid vaccine withdrawal
Proactive Investors· 2 days agoAstraZeneca PLC (LSE:AZN), the FTSE 100's largest constituent, surged 1.8% today after it said it would be withdrawing its COVID vaccine from global...
AstraZeneca to withdraw COVID vaccine globally as demand dips
Reuters· 2 days ago, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine...
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
Bloomberg· 2 days agoAstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 12 hours ago(NASDAQ: ONCY) (TSX: ONC), Candel Therapeutics, Inc. (NASDAQ: CADL), AstraZeneca PLC (NASDAQ: AZN), Halozyme Therapeutics, Inc. (NASDAQ: HALO), and Janux ...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 4 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
ANGLE teams up with AstraZeneca on a second assay
Proactive Investors· 7 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to develop an...
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
WTNH-TV New Haven· 6 days ago(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLMA),...
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3...
Morningstar· 2 days agoFN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical studies are looking for elite performance nutritional ...
